NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
Back to search
Official data from USPTO
ELISPHYRE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ELISPHYRE
ST13
US500000088832104Class
5, 9, 10
Filing
88832104
Registration
7629138
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
12/31/2024
Trademark type
Word
Nice classes
5, 9, 10
Filing date
03/12/2020
Registration date
12/31/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Hellerup, DK
Examiner
HOPKINS, SARAH COLLEEN
Law office
N50
Current location
INTENT TO USE SECTION
Holders and representatives
Holders
Ascendis Pharma Bone Diseases A/S
Representatives
Shannon Marie McKeon DYKEMA GOSSETT PLLC
Technical classification
Nice Classes
Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorderspharmaceutical preparations for the treatment of endocrine disorderspharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical usediagnostic preparations for identifying and detecting hypoparathyroidismendocrine disorders and bone disorders
Class 9
Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatmentpatient assistance and health insurance in the field of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersa downloadable software application for sharing information related to hypoparathyroidismgrowth disordersendocrine disorders and bone disorders and the treatment of hypoparathyroidismgrowth disordersendocrine disordersbone disorders for use by patients with growth hormone disordershypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersdownloadable software that coordinates the delivery of health care services between health care providerspatients and those parties responsible for the payment of health care servicesdownloadable software that allows individuals seeking medical educationinformation and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersdownloadable software that enables health care providers to monitor patientscommunicate clinical information relevant to a patient's careprovide and exchange information concerning patients and the health care services provided to patients; downloadable softwaredownloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable softwaredownloadable software applications and downloadable mobile applications for the measurement of heightweightblood pressureserum calciumblood glucoseheart rate; downloadable softwaredownloadable software applications and downloadable mobile applications for providingexchangingretrieving and analyzing health and healthcare information; downloadable software for medical purposesfor formattingviewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersa downloadable software application for providing healthcare-related informationmedication reminderstracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders
Class 10
Medical devices for injectiondosage and control of pharmaceuticalsmedical devices for injectiondosage measurement and monitoring of pharmaceuticals for the treatment of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders; syringes for medical purposes and for injections; syringes for injection for medical and surgical usesyringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disordershypoparathyroidism and skeletal dysplasia; medical apparatusinfusion and injection devices for administering drugs; medical apparatus for diagnostic purposesmedicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
12/10/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/26/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
08/26/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/29/2024
EX5G
SOU EXTENSION 5 GRANTED
02/28/2024
EXT5
SOU EXTENSION 5 FILED
02/28/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/28/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/01/2023
EX4G
SOU EXTENSION 4 GRANTED
08/30/2023
EXT4
SOU EXTENSION 4 FILED
08/30/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/30/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/24/2023
EX3G
SOU EXTENSION 3 GRANTED
02/22/2023
EXT3
SOU EXTENSION 3 FILED
02/22/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/22/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/25/2022
EX2G
SOU EXTENSION 2 GRANTED
08/23/2022
EXT2
SOU EXTENSION 2 FILED
08/23/2022
EEXT
SOU TEAS EXTENSION RECEIVED
08/23/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/26/2022
EX1G
SOU EXTENSION 1 GRANTED
01/24/2022
EXT1
SOU EXTENSION 1 FILED
01/24/2022
EEXT
SOU TEAS EXTENSION RECEIVED
01/24/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/31/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/06/2021
PUBO
PUBLISHED FOR OPPOSITION
07/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/16/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/26/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/03/2021
GNSL
LETTER OF SUSPENSION E-MAILED
05/03/2021
CNSL
SUSPENSION LETTER WRITTEN
05/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2021
ALIE
ASSIGNED TO LIE
03/11/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/09/2020
GNRT
NON-FINAL ACTION E-MAILED
06/09/2020
CNRT
NON-FINAL ACTION WRITTEN
06/09/2020
DOCK
ASSIGNED TO EXAMINER
06/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/18/2020
NWAP
NEW APPLICATION ENTERED
03/16/2020
Continuous trademark protection
Get notified about every new filing that threatens ELISPHYRE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.